Scholarlink

<p>Accumulation of amyloid-β (Aβ) and neurofibrillary tangles (NFTs) are followed by the activation of glia cells and infiltration of peripheral immune cells that collectively accelerate neurodegeneration in preclinical AD models. Yet, the role of neuroinflammation for neuronal injury and disease progression in preclinical and early symptomatic AD remains elusive. Here, we combined multiplexed immunoassays and SomaScan proteomics of the cerebrospinal fluid (CSF) with MRI and PET brain imaging of people across the AD continuum to identify pathways that are associated with AD progression. Unbiased clustering revealed that glia-mediated inflammation, activation of cell death pathways (CDPs) and synaptic pathologies were among the earliest Aβ-induced changes, and were associated with disease progression in preclinical AD. Mediation analysis revealed that activation of CDPs were decisive drivers of inflammation in early symptomatic AD. The cycle of glia-mediated neuroinflammation and neuronal injury characterizes preclinical AD and has implications for novel treatment approaches.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Glia inflammation and cell death pathways drive disease progression in preclinical and early AD

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月10日

查看全文
  • Marcel S Woo,
  • Joseph Therriault,
  • Seyyed Ali Hosseini,
  • Yi-Ting Wang,
  • Arthur C Macedo,
  • Nesrine Rahmouni,
  • Étienne Aumont,
  • Stijn Servaes,
  • Cécile Tissot,
  • Jaime Fernandez-Arias,
  • Lydia Trudel,
  • Brandon Hall,
  • Gleb Bezgin,
  • Kely Quispialaya-Socualaya,
  • Marina Goncalves,
  • Tevy Chan,
  • Jenna Stevenson,
  • Yansheng Zheng,
  • Stuart Mitchell,
  • Robert Hopewell,
  • Ilaria Pola,
  • Kubra Tan,
  • Guglielmo Di Molfetta,
  • Firoza Z Lussier,
  • Gassan Massarweh,
  • Paolo Vitali,
  • Jean-Paul Soucy,
  • Serge Gauthier,
  • Nicholas J Ashton,
  • Kaj Blennow,
  • Tharick A Pascoal,
  • Henrik Zetterberg,
  • Andréa L Benedet,
  • Pedro Rosa-Neto

摘要

Accumulation of amyloid-β (Aβ) and neurofibrillary tangles (NFTs) are followed by the activation of glia cells and infiltration of peripheral immune cells that collectively accelerate neurodegeneration in preclinical AD models. Yet, the role of neuroinflammation for neuronal injury and disease progression in preclinical and early symptomatic AD remains elusive. Here, we combined multiplexed immunoassays and SomaScan proteomics of the cerebrospinal fluid (CSF) with MRI and PET brain imaging of people across the AD continuum to identify pathways that are associated with AD progression. Unbiased clustering revealed that glia-mediated inflammation, activation of cell death pathways (CDPs) and synaptic pathologies were among the earliest Aβ-induced changes, and were associated with disease progression in preclinical AD. Mediation analysis revealed that activation of CDPs were decisive drivers of inflammation in early symptomatic AD. The cycle of glia-mediated neuroinflammation and neuronal injury characterizes preclinical AD and has implications for novel treatment approaches.